mitomycin has been researched along with cyclin d1 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Habuchi, T; Higashi, S; Ito, M; Kamoto, T; Nishiyama, H; Ogawa, O; Tsuchiya, N; Wang, L; Watanabe, J | 1 |
| Guan, HG; Li, C; Li, P; Qian, HX; Qin, L; Wang, ZW; Xue, WJ; Zhou, XJ | 1 |
| Liu, XJ; Lu, YY; Su, SB; Wang, XF; Zhang, H; Zhou, QM | 1 |
| Jiao, M; Li, C; Mei, N; Tian, T; Zhao, N | 1 |
4 other study(ies) available for mitomycin and cyclin d1
| Article | Year |
|---|---|
Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer.
Topics: Aged; Alternative Splicing; Antineoplastic Agents, Alkylating; BCG Vaccine; Carcinoma in Situ; Carcinoma, Transitional Cell; Combined Modality Therapy; Cyclin D1; Cystectomy; Disease Progression; Female; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Humans; Immunotherapy, Active; Incidence; Life Tables; Male; Middle Aged; Mitomycin; Polymorphism, Genetic; Prognosis; Proportional Hazards Models; Proto-Oncogenes; Risk; Salvage Therapy; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms | 2004 |
RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Topics: Adult; Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; China; Cyclin D1; DNA Replication; Female; Gene Expression Regulation, Neoplastic; Hepatitis B; Hepatitis B Surface Antigens; Humans; Liver Neoplasms; Logistic Models; Male; Mice; Mice, Nude; Mitomycin; Mutation; Odds Ratio; Risk Assessment; Risk Factors; Time Factors; Transfection; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2008 |
Curcumin enhanced antiproliferative effect of mitomycin C in human breast cancer MCF-7 cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Breast; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Curcumin; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 2; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Mitomycin | 2011 |
Biological features, gene expression profile, and mechanisms of drug resistance of two- and three-dimensional hepatocellular carcinoma cell cultures.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Cisplatin; Cyclin D1; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Minichromosome Maintenance Complex Component 2; Minichromosome Maintenance Complex Component 3; Mitomycin; Paclitaxel; Transcriptome | 2021 |